A comprehensive analysis of nearly 1,600 tumor samples has found that CT-X genes are expressed in nearly half the breast cancers that lack the estrogen receptor. CT-X gene products are the targets of therapeutic cancer vaccines already in phase III clinical trials for lung cancer and melanoma.
Full article >>
Thursday, July 30, 2009
Could Therapeutic Vaccines Treat Hard-To-Beat Breast Cancers?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment